SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-006143
Filing Date
2019-05-08
Accepted
2019-05-07 18:21:56
Documents
65
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 AERI 3.31.2019 aeri10-qx33119.htm 10-Q 696808
2 AERI 3.31.2019 EX 31.1 aeri3312019ex311.htm EX-31.1 16408
3 AERI 3.31.2019 EX 31.2 aeri3312019ex312.htm EX-31.2 16505
4 AERI 3.31.2019 EX 32.1 aeri3312019ex321.htm EX-32.1 10033
5 AERI 3.31.2019 EX 32.2 aeri3312019ex322.htm EX-32.2 9975
  Complete submission text file 0001628280-19-006143.txt   4083215

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aeri-20190331.xml EX-101.INS 628662
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aeri-20190331.xsd EX-101.SCH 35737
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aeri-20190331_cal.xml EX-101.CAL 64399
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aeri-20190331_def.xml EX-101.DEF 176661
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aeri-20190331_lab.xml EX-101.LAB 529963
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aeri-20190331_pre.xml EX-101.PRE 311944
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36152 | Film No.: 19804550
SIC: 2836 Biological Products, (No Diagnostic Substances)